Report ID : 10060011 |
Published Date : 21 Oct 2022 |
Report Format : PDF,PPT |
Delivery Timeline :48-72 Business Hours
The global real-time PCR (qPCR) and digital PCR (dPCR) market is estimated to be around USD 3 billion in 2021. It is expected to grow at a CAGR of 9% during the forecast period 2022-2030. Epidemiology of target diseases and rapid technological advances such as the development of high-performance systems, qPCR systems and dPCR systems can be major growth drivers.
According to the World Health Organization (WHO), cancer was the leading cause of death in 2018, killing 9.6 million people worldwide. The World Health Organization (WHO) estimates that 36.9 million people were infected with HIV in 2017. It is associated with infectious diseases. The worlds leading causes of death in 2016. The high prevalence of these diseases should predict the future market.
In addition, the continued efforts of PCR manufacturers to develop new systems and kits for use in molecular testing will drive the growth of the qPCR and dPCR market. For example, in January 2019, QIAGEN NV announced plans to develop a next-generation dPCR system that will hit the market in 2020. These new systems are expected to provide highly automated workflows and faster response times than digital PCR. operating system. This can be a significant competitive advantage for a company.
In addition, extensive applications of qPCR and dPCR techniques are expected to further enhance the reliability of the target. These techniques are widely used in basic and clinical research. They are widely used in fields such as human genetic testing, forensics, pathogen diagnosis and infectious disease testing. Expansion of Food Microbiology and Veterinary Applications is Expected to Strengthen the Market.
TECHNICAL INFORMATION :
On the basis of technology, the real-time PCR (qPCR) and digital PCR (dPCR) market is segmented into quantitative and digital. PCR easily reached #1 in market share in 2018. Continuously growing demand in fields such as gene mutation analysis, gene expression and genotyping is driving interest in developing operating system platforms for long-term care (POC).
Digital PCR is a next-generation test method that can accurately identify nucleic acids. These systems offer higher sensitivity and accuracy than other PCR-based approaches and help the industry grow strongly during the forecast period.
PRODUCT OVERVIEW:
Based on product, the market is segmented into Consumables, Reagents, Equipment, Software, and Services. Consumables and reagents were the first segment to have the largest market share in 2020. This segment is expected to grow significantly compared to other regions with the introduction of new PCR test kits. In October 2017, AOAC International, an independent standards development agency for the Bio-Rad Institute, approved the iQ-Check (Real-Time PCR Kit) as an official analytical method for detecting Salmonella strains in raw meat. The approval process paved the way for the group to be used in a wide range of industrial applications in the meat industry.
APPLICATION INSIGHTS:
On the basis of application, the market is segmented into research, clinical, forensic, etc. The research program played an important role in 2018. QPCR and dPCR systems are widely used in research applications such as stem cell research, genetic disease research, and oncology. The mass use of these systems is due to features such as improved data security and faster response times. The clinical applications industry will experience the highest annual growth rate of 8.7% during the forecast period due to increasing acceptance of automated procedures.
REGIONAL APPROACH :
North America dominated the regional segment in 2020, introducing new test systems and kits from PCR manufacturers. In September 2018, Thermo Fisher Scientific Inc. announced the rapid detection of mastitis pathogens in cows using Veetmax MastiType, a qPCR-based test package. Additionally, the strong presence of major PCR manufacturers in the region should predict the regions growth and growing demand for rapid diagnostic tests during this period. Asia Pacific is expected to witness the fastest CAGR of 12% during the forecast period. The increasing number of patients due to the high prevalence of chronic infections and increasing patient awareness for the early detection of these diseases are expected to stimulate the demand for PCR products and grow the market.
OVERVIEW OF MARKET SHARS OF qPCR AND dPCR:
Key market players have always focused on staying competitive as a strategic business indicator. The most important actions of actors are the introduction of new products, collaborations and partnerships with institutions and companies, and mergers and acquisitions.
In January 2019, QIAGEN N.V announced the acquisition of PCR FORMULATRIX digital assets for $260 million. This acquisition is a good step forward in the company strategy to bring a new digital PCR operating system to market in 2020 through the integration of advanced FORMULATRIX dPCR technology.
Bio-Rad Labs is some of the major players in the qPCR and dPCR market domain. Thermo Fisher Scientific Society, Qiagen NV, Abbott Laboratories, Inc. Agilent Technologies, Inc. Biomarix SA, Fluidigm Company. and f. Hoffman La method.
SEGMENTS REPORTED:
The report forecasts global, regional and national sales growth and provides an analysis of the latest industry trends for each sub-sector from 2022-2030. PCR Market (dPCR) by Technology, Product, Application, Real-Time (qPCR) and Industry Digital PCR Report: Technology Forecast (Sales, $1M, 2022-203) Quantitative Outlook for Digital Products (Sales, $1M)) 2022-203) Software and Services Forecast Program for Consumables and Reagent Equipment (Sales, US$1M, 2022-203) Clinical Causes, Blood Testing, Oncology Testing, Other Research, Forensics, etc.
